Featured Research

from universities, journals, and other organizations

What decides neural stem cell fate? Only cells expressing SOX2 gatekeeper gene have potential to become neurons

Date:
May 5, 2011
Source:
Sanford-Burnham Medical Research Institute
Summary:
Researchers have found that expression of a gene called SOX2 maintains the potential for neural crest stem cells to become neurons in the peripheral nervous system. Their results could help better inform therapies aimed at neurocristopathies, diseases caused by defects in the neural crest.

Early in embryonic development, the neural crest -- a transient group of stem cells -- gives rise to parts of the nervous system and several other tissues. But little is known about what determines which cells become neurons and which become other cell types. A team led by Dr. Alexey Terskikh at Sanford-Burnham Medical Research Institute (Sanford-Burnham) recently found that expression of a gene called SOX2 maintains the potential for neural crest stem cells to become neurons in the peripheral nervous system, where they interface with muscles and other organs.

Their results, published online May 5 by the journal Cell Stem Cell, could help better inform therapies aimed at neurocristopathies, diseases caused by defects in the neural crest or neurons, which include microphthamia and CHARGE syndrome.

The SOX2 gene encodes a transcription factor, a type of protein that switches other genes on or off. SOX2 is one of two key genes researchers use to generate induced pluripotent stem cells (iPSCs), which are capable of differentiating into all cell types for research and potential therapeutic applications.

"In this study, we looked at SOX2's role in cells of the peripheral nervous system and discovered that it's required to sustain multipotency -- the ability to differentiate into several cell types in the peripheral nervous system, including neurons and glia," explained Dr. Terskikh, assistant professor in Sanford-Burnham's Del E. Webb Neuroscience, Aging and Stem Cell Research Center.

Using an embryonic stem cell model, Dr. Terskikh and colleagues showed that stem cells in the developing nervous system start out with SOX2, but lose it at the stage when they are considered migratory neural crest cells. Later, as neural crest stem cells aggregate at a subsequent point in development, SOX2 is regained only by those cells fated to become neurons. Neural crest stem cells that remain SOX2-free differentiate into other cell types, but never become neurons.

To determine how SOX2 controls this stage in nervous system development, the researchers looked at the genes it acts upon. They found that SOX2 switches on neurogenin-1 and Mash-1, two genes that support neuronal survival in both the central and peripheral nervous systems.

"If we prevent neural crest stem cells from re-expressing SOX2, we don't get neurons. If we try to push these SOX2-deficient cells to become neurons, they die, but they can readily give rise to glia or smooth muscle cells," Dr. Terskikh said. "We think that one function of SOX2 is to keep cells multipotent or pluripotent for one reason -- if they need to become a neuron later in development. We hope this finding will be useful to researchers studying neural crest development and stem cell differentiation."

Dr. Terskikh is supported by the California Institute for Regenerative Medicine (CIRM). Co-authors of this study include Flavio Cimadamore, Elena Giusto, Ksenia Gnedeva, Giulio Cattarossi, Amber Miller and Laurence M. Brill at Sanford-Burnham, Katherine Fishwick and Marianne Bronner-Fraser at the California Institute of Technology and Stefano Pluchino from the Institute of Experimental Neurology, IRCCS, in Italy.


Story Source:

The above story is based on materials provided by Sanford-Burnham Medical Research Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Flavio Cimadamore, Katherine Fishwick, Elena Giusto, Ksenia Gnedeva, Giulio Cattarossi, Amber Miller, Stefano Pluchino, Laurence M. Brill, Marianne Bronner-Fraser, Alexey V. Terskikh. Human ESC-Derived Neural Crest Model Reveals a Key Role for SOX2 in Sensory Neurogenesis. Cell Stem Cell, 2011; 8 (5): 538-551 DOI: 10.1016/j.stem.2011.03.011

Cite This Page:

Sanford-Burnham Medical Research Institute. "What decides neural stem cell fate? Only cells expressing SOX2 gatekeeper gene have potential to become neurons." ScienceDaily. ScienceDaily, 5 May 2011. <www.sciencedaily.com/releases/2011/05/110505123944.htm>.
Sanford-Burnham Medical Research Institute. (2011, May 5). What decides neural stem cell fate? Only cells expressing SOX2 gatekeeper gene have potential to become neurons. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2011/05/110505123944.htm
Sanford-Burnham Medical Research Institute. "What decides neural stem cell fate? Only cells expressing SOX2 gatekeeper gene have potential to become neurons." ScienceDaily. www.sciencedaily.com/releases/2011/05/110505123944.htm (accessed August 27, 2014).

Share This




More Health & Medicine News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WHO Calls for Ban on E-Cigarette Sales to Minors

WHO Calls for Ban on E-Cigarette Sales to Minors

AFP (Aug. 26, 2014) The World Health Organization called Tuesday on governments should ban the sale of e-cigarettes to minors, warning that they pose a "serious threat" to foetuses and young people. Duration: 01:44 Video provided by AFP
Powered by NewsLook.com
Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Have You Ever Been 'Sleep Drunk?' 1 in 7 Has

Newsy (Aug. 26, 2014) A study published in the journal "Neurology" interviewed more than 19,000 people and found 15 percent suffer from being "sleep drunk." Video provided by Newsy
Powered by NewsLook.com
Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Does Medical Marijuana Reduce Painkiller Overdose Deaths?

Newsy (Aug. 26, 2014) A new study found fewer deaths from prescription drug overdoses in states that have legalized medical marijuana. But experts disagree on the results. Video provided by Newsy
Powered by NewsLook.com
Official: British Ebola Sufferer Receiving Experimental Drug

Official: British Ebola Sufferer Receiving Experimental Drug

AFP (Aug. 26, 2014) A British nurse infected with Ebola while working in Sierra Leone is being given the same experimental drug used on two US missionaries who have recovered for the disease, doctors in London say. Duration: 00:44 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins